Ezzeldin Muktar Abdurahman

From WikiMD's Medical Encyclopedia

Ezzeldin Muktar Abdurahman is a renowned pharmacologist and medical researcher known for his significant contributions to the field of pharmacology. His research primarily focuses on the development of new drugs and the improvement of existing ones, with a particular emphasis on cancer treatment.

Early Life and Education[edit]

Ezzeldin Muktar Abdurahman was born and raised in Sudan. He pursued his undergraduate studies in Pharmacy at the University of Khartoum, where he developed a keen interest in pharmacology. He then moved to the United States for his postgraduate studies, earning a PhD in Pharmacology from the University of California, San Francisco.

Career[edit]

Abdurahman has held various positions in academia and the pharmaceutical industry. He has worked as a professor at several prestigious universities, teaching courses on pharmacology and conducting research. In the pharmaceutical industry, he has been involved in the development of several groundbreaking drugs, particularly in the field of oncology.

Research[edit]

Abdurahman's research has been instrumental in the development of new drugs and therapies for cancer treatment. His work has led to significant advancements in the understanding of how drugs interact with the body and how they can be modified to improve their effectiveness and reduce side effects.

Awards and Recognition[edit]

Abdurahman's contributions to pharmacology have earned him numerous awards and recognition. He is a member of several professional organizations, including the American Society for Pharmacology and Experimental Therapeutics.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.